Cargando…
293. Lung Cancer and Hematologic Malignancy ( HM) Patients Are Associated with the Highest Risk of Progressing to Severe Disease and Mortality in Cancer Patients with COVID-19
BACKGROUND: Several studies have shown that underlying cancer is a risk factor for progression of COVID-19 to severe illness and fatal outcome but there is very little data that specifies which underlying cancer puts this patient population at the highest risk. METHODS: We retrospectively collected...
Autores principales: | Chaftari, Anne-Marie, Malek, Alexandre, Dagher, Hiba, Jiang, Ying, Bayle, Arnaud, Bhinder, Arvinder, Cruz, Ana Fernandez, Siddiqui, Bilal, Somer, Robert, Datoguia, Tarcila, Slavin, Monica, Dragvich, Tomislav, Gorak, Edward, Mori, Nobuyoshi, Hachem, Ray Y, Raad, Issam I |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8690450/ http://dx.doi.org/10.1093/ofid/ofab466.495 |
Ejemplares similares
-
372. Comparing the Outcome of COVID-19 in Cancer and Non-Cancer Patients: an International Multicenter Study
por: Hachem, Ray Y, et al.
Publicado: (2020) -
22. International Multicenter Study Comparing Cancer to Non-Cancer Patients with COVID-19: Impact of Risk Factors and Treatment Modalities on Outcome
por: Hachem, Ray Y, et al.
Publicado: (2021) -
1636. Risk of Latent Tuberculosis Reactivation in Patients Treated with Checkpoint Inhibitors Immunotherapy Compared to Other Anti-Cancer Therapies including Hematopoietic Cell Transplantation
por: Malek, Alexandre, et al.
Publicado: (2020) -
357. A Comparison of Chest CT Findings in Cancer and Non-Cancer Patients with COVID-19
por: Malek, Alexandre, et al.
Publicado: (2021) -
1228. The Role of Procalcitonin (PCT) and Lactic Acid in Febrile Neutropenic Cancer Patients in an Oncological Emergency Center
por: Chaftari, Patrick, et al.
Publicado: (2020)